RARS1 and hepatocellular carcinoma: Consistent with these computational predictions, multiplex immunofluorescence staining of HCC tissues demonstrated that RARS1-high tumors displayed a markedly higher proportion of CD206+ macrophages compared with RARS1-low tumors (Figure 8C).